Cardiovascular Outcomes After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter observational study using the EUROCRINE registry to collect real-world data on patients undergoing adrenalectomy for pheochromocytoma or non-secreting tumors. It will add study-specific variables via the my-EUROCRINE module and record preoperative preparation, intraoperative blood pressure events, and cardiovascular outcomes up to day 30. The study uses validated criteria to define hypertensive crises and other cardiovascular events, aiming to reflect routine clinical practice across centers. Consecutive enrollment helps ensure the data represent typical patient experiences and management. Central Hospital, Nancy leads the study with European collaborators.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing adrenalectomy for pheochromocytoma
* Patients undergoing adrenalectomy for non-secreting tumors. Patients with non-secreting tumors are those with indication for adrenalectomy in the Eurocrine database corresponding to " excluding malignancy ".

Exclusion Criteria:

* Children and minors (\<18 years).
* Pregnant women.
* Patients with other indication for adrenalectomy in Eurocrine (i.e. Adrenocortical cancer, Cushing, Primary aldosteronism, Metastasis).

Where it's running

• CHRU Nancy
  Vandœuvre-lès-Nancy, Lorraine, France Recruiting

Study contacts

• Principal investigator: laurent BRUNAUD, MD, PhD — University of Lorraine, CHRU Nancy,
• Study coordinator: laurent BRUNAUD, MD, PhD
• Email: l.brunaud@chru-nancy.fr
• Phone: +33 0383153109

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Belzutifan and catecholamine metabolism in pheochromocytoma/paraganglioma

  This study tests whether Belzutifan can change how catecholamines are produced and broken down in adults with pheochromocytoma or paraganglioma.

  Recruiting Phase 2 Cambridge University Hospitals NHS Foundation Trust · Cambridge, Cambridgeshire · NCT07680205

• NET- and somatostatin-targeted PET/SPECT imaging to find and stage neuroblastoma and pheochromocytoma/paraganglioma

  This study will try different PET and SPECT tracers to see if they can accurately find and stage tumors in children and adults with neuroblastoma or pheochromocytoma/paraganglioma.

  Recruiting Nanjing First Hospital, Nanjing Medical University · Nanjing, Jiangsu · NCT07195500

• Tropicamide/phenylephrine safety in hospitalized patients

  This project will see if certain health factors make hospitalized adults more likely to have side effects after getting tropicamide/phenylephrine eye drops.

  Recruiting Instituto de Oftalmología Fundación Conde de Valenciana · Mexico City, Mexico Ciy · NCT07178600

• At-home cardiac rehabilitation for adolescents at risk for heart failure

  This study is testing whether an at-home exercise and nutrition program can help young cancer survivors aged 10-21 improve their heart health and overall well-being.

  Recruiting Children's Hospital Los Angeles · Los Angeles, California · NCT06826534

• Evaluating 18F-MFBG PET Imaging for Pheochromocytoma

  This study is testing a new imaging method called 18F-MFBG PET to see if it can help people with pheochromocytoma get better and faster pictures of their tumors compared to traditional methods.

  Recruiting at 2 sites First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT06813742

• Using dapagliflozin to reduce cardiovascular risk after hypertensive pregnancies

  This study is testing if the medication dapagliflozin can help reduce heart risks for women who had high blood pressure during pregnancy after they give birth.

  Recruiting Phase 4 University of Michigan · Ann Arbor, Michigan · NCT06785116

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.